← Open Payments lookup

KALEN KNOPP: Open Payments

NPI 1184094344 · KIMBERLY, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$237 in 13 payments from 9 companies in 2025. Trend: 2023 $97 · 2024 $204 · 2025 $237

Food & beverage: $237
CompanyPaymentsAmount
Novo Nordisk Inc3$53
Grifols USA, LLC1$37
AstraZeneca Pharmaceuticals LP2$34
Lilly USA, LLC2$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Amgen Inc.1$15
ABBVIE INC.1$15
Medtronic, Inc.1$14

Products named: Prolastin-C Liquid, FARXIGA, MOUNJARO, Rybelsus, XIFAXAN, CAPLYTA, Ozempic, Wegovy.

Industry payments across ID — which companies pay providers there.